✦ LIBER ✦

Analysis of Survival Data from a Randomized Trial with All-or-None Compliance: Estimating the Cost-Effectiveness of a Cancer Screening Program

✍ Scribed by Stuart G. Baker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Causal Proportional Hazards Estimator

✍ T. Loeys; E. Goetghebeur 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Intent-to-treat analysis of repeated mea

✍ B.M. Johnstone; R.L. Obenchain; E.T. Edgell; T.W Croghan; S.L. Tunis; T.J. Knies 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 180 KB

The cost-effectiveness of population H p

✍ Moayyedi, Paul; Mason, James; Forman, David; Drummond, Michael F.; Axon, Anthony 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Does neoadjuvant cisplatin-based chemoth

✍ Advanced Bladder Cancer Overview Collaboration: (Collaborators: D. Ghersi L.A. S 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 616 KB

An analysis of the treatment effect of p

✍ Melanie Poulin-Costello, Laurent Azoulay, Eric Van Cutsem… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 434 KB

PCN72 COST-EFFECTIVENESS OF LETROZOLE AN

✍ J Karnon; S Kaura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB